tm logo

Monitor this mark

View On USPTO

EGRIFTA SV
Live/Registered
REGISTERED

on 16 Jun 2020

Last Applicant/ Owned by

Theratechnologies Inc.

7865 SAINT-LAURENT BOULEVARD

MONTREAL, QUEBEC

CA

H2R1X1

Serial Number

88200431 filed on 20th Nov 2018

Registration Number

6077575 registered on 16th Jun 2020

in the Principal Register

Correspondent Address

Sebastian Lovera

Sebastian Lovera

1040 Avenue of the Americas

New York NY 10018

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

EGRIFTA SV

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury

First Use Date in General

03rd Dec 2019

First Use Date in Commerce

03rd Dec 2019

Mark Details

Serial Number

No 88200431

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 1T18707362

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
20th Jan 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20th Jan 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
20th Jan 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20th Jan 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20th Jan 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20th Jan 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20th Jan 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
16th Jun 2020REGISTERED-PRINCIPAL REGISTER
31st Mar 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31st Mar 2020PUBLISHED FOR OPPOSITION